{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:25:33Z","timestamp":1759940733687},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11064-024-04167-z","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T06:02:20Z","timestamp":1717999340000},"page":"2319-2335","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic"],"prefix":"10.1007","volume":"49","author":[{"given":"Shweta","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bhawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"12","key":"4167_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.5483\/bmbrep.2016.49.12.184","volume":"49","author":"J Kim-Ha","year":"2016","unstructured":"Kim-Ha J, Kim YJ (2016) Age-related epigenetic regulation in the brain and its role in neuronal diseases. BMB Rep 49(12):671\u2013680. https:\/\/doi.org\/10.5483\/bmbrep.2016.49.12.184","journal-title":"BMB Rep"},{"issue":"19","key":"4167_CR2","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.3390\/ijerph191912495","volume":"19","author":"EA Ayeni","year":"2022","unstructured":"Ayeni EA, Aldossary AM, Ayejoto DA, Gbadegesin LA, Alshehri AA, Alfassam HA, Afewerky HK, Almughem FA, Bello SM, Tawfik EA (2022) Neurodegenerative diseases: implications of environmental and climatic influences on neurotransmitters and neuronal hormones activities. Int J Environ Res Public Health 19(19):12495. https:\/\/doi.org\/10.3390\/ijerph191912495","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4167_CR3","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1186\/s12889-019-7762-5","volume":"19","author":"P Maresova","year":"2019","unstructured":"Maresova P, Javanmardi E, Barakovic S, Barakovic Husic J, Tomsone S, Krejcar O, Kuca K (2019) Consequences of chronic diseases and other limitations associated with old age\u2014a scoping review. BMC Public Health 19(1):1431. https:\/\/doi.org\/10.1186\/s12889-019-7762-5","journal-title":"BMC Public Health"},{"key":"4167_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM et al (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4167_CR5","doi-asserted-by":"publisher","first-page":"317S","DOI":"10.1093\/ajcn\/81.1.317S","volume":"81","author":"IC Arts","year":"2005","unstructured":"Arts IC, Hollman PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81(1):317S-325S. https:\/\/doi.org\/10.1093\/ajcn\/81.1.317S","journal-title":"Am J Clin Nutr"},{"issue":"14","key":"4167_CR6","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","volume":"28","author":"RA Arias-S\u00e1nchez","year":"2023","unstructured":"Arias-S\u00e1nchez RA, Torner L, Fenton Navarro B (2023) Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection. Molecules (Basel, Switzerland) 28(14):5415. https:\/\/doi.org\/10.3390\/molecules28145415","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5\u20136","key":"4167_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10284150400020482","volume":"7","author":"G Casadesus","year":"2004","unstructured":"Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu X, Lee HG, Smith MA, Joseph JA (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7(5\u20136):309\u2013316. https:\/\/doi.org\/10.1080\/10284150400020482","journal-title":"Nutr Neurosci"},{"key":"4167_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","volume":"236","author":"SS Karuppagounder","year":"2013","unstructured":"Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP (2013) Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson\u2019s disease in rats. Neuroscience 236:136\u2013148. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.01.032","journal-title":"Neuroscience"},{"issue":"24","key":"4167_CR9","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.3390\/nu14245373","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yu W, Zhang L, Wang M, Chang W (2022) The interaction of polyphenols and the gut microbiota in neurodegenerative diseases. Nutrients 14(24):5373. https:\/\/doi.org\/10.3390\/nu14245373","journal-title":"Nutrients"},{"key":"4167_CR10","doi-asserted-by":"publisher","first-page":"5288698","DOI":"10.1155\/2022\/5288698","volume":"2022","author":"L Yan","year":"2022","unstructured":"Yan L, Guo MS, Zhang Y et al (2022) Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities. Oxid Med Cell Longev 2022:5288698. https:\/\/doi.org\/10.1155\/2022\/5288698","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"4167_CR11","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.3390\/ijms19113425","volume":"19","author":"C Tiffon","year":"2018","unstructured":"Tiffon C (2018) The impact of nutrition and environmental epigenetics on human health and disease. Int J Mol Sci 19(11):3425. https:\/\/doi.org\/10.3390\/ijms19113425","journal-title":"Int J Mol Sci"},{"key":"4167_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41538-017-0008-y","volume":"1","author":"SJ Korosi","year":"2017","unstructured":"Korosi SJ, Lay\u00e9 AS et al (2017) Food for thought: how nutrition impacts cognition and emotion. npj Sci Food 1:7. https:\/\/doi.org\/10.1038\/s41538-017-0008-y","journal-title":"npj Sci Food"},{"issue":"7","key":"4167_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrn2421","volume":"9","author":"F G\u00f3mez-Pinilla","year":"2008","unstructured":"G\u00f3mez-Pinilla F (2008) Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9(7):568\u2013578. https:\/\/doi.org\/10.1038\/nrn2421","journal-title":"Nat Rev Neurosci"},{"key":"4167_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fimmu.2015.00467","volume":"6","author":"LR Ferguson","year":"2015","unstructured":"Ferguson LR (2015) Nutritional modulation of gene expression: might this be of benefit to individuals with Crohn\u2019s disease? Front Immunol 6:467. https:\/\/doi.org\/10.3389\/fimmu.2015.00467","journal-title":"Front Immunol"},{"key":"4167_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/760689","volume":"2015","author":"RE Hodges","year":"2015","unstructured":"Hodges RE, Minich DM (2015) Modulation of metabolic detoxification pathways using foods and food-derived components: a scientific review with clinical application. J Nutr Metab 2015:760689. https:\/\/doi.org\/10.1155\/2015\/760689","journal-title":"J Nutr Metab"},{"issue":"1","key":"4167_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0757.2012.00458.x","volume":"64","author":"DR Dawson 3rd","year":"2014","unstructured":"Dawson DR 3rd, Branch-Mays G, Gonzalez OA, Ebersole JL (2014) Dietary modulation of the inflammatory cascade. Periodontol 2000 64(1):161\u2013197. https:\/\/doi.org\/10.1111\/j.1600-0757.2012.00458.x","journal-title":"Periodontol 2000"},{"issue":"11","key":"4167_CR17","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1021\/jf900612n","volume":"57","author":"MH Pan","year":"2009","unstructured":"Pan MH, Lai CS, Dushenkov S, Ho CT (2009) Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem 57(11):4467\u20134477. https:\/\/doi.org\/10.1021\/jf900612n","journal-title":"J Agric Food Chem"},{"key":"4167_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2019.00033","volume":"10","author":"AR Vasconcelos","year":"2019","unstructured":"Vasconcelos AR, Dos Santos NB, Scavone C, Munhoz CD (2019) Nrf2\/ARE pathway modulation by dietary energy regulation in neurological disorders. Front Pharmacol 10:33. https:\/\/doi.org\/10.3389\/fphar.2019.00033","journal-title":"Front Pharmacol"},{"issue":"2","key":"4167_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12035-013-8498-3","volume":"48","author":"A Virmani","year":"2013","unstructured":"Virmani A, Pinto L, Binienda Z, Ali S (2013) Food, nutrigenomics, and neurodegeneration neuroprotection by what you eat! Mol Neurobiol 48(2):353\u2013362. https:\/\/doi.org\/10.1007\/s12035-013-8498-3","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4167_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000503451","volume":"19","author":"AG Pacholko","year":"2019","unstructured":"Pacholko AG, Wotton CA, Bekar LK (2019) Poor diet, stress, and inactivity converge to form a \u201cperfect storm\u201d that drives Alzheimer\u2019s disease pathogenesis. Neurodegener Dis 19(2):60\u201377. https:\/\/doi.org\/10.1159\/000503451","journal-title":"Neurodegener Dis"},{"issue":"1","key":"4167_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41392-022-01104-w","volume":"7","author":"Q Wu","year":"2022","unstructured":"Wu Q, Gao ZJ, Yu X, Wang P (2022) Dietary regulation in health and disease. Signal Transduct Target Ther 7(1):252. https:\/\/doi.org\/10.1038\/s41392-022-01104-w","journal-title":"Signal Transduct Target Ther"},{"key":"4167_CR22","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.96746","author":"W Chaiwangyen","year":"2021","unstructured":"Chaiwangyen W (2021) The impact of dietary compounds in functional foods on MicroRNAs expression. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.96746","journal-title":"IntechOpen"},{"issue":"4","key":"4167_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/138920101504140825113815","volume":"15","author":"R Rodrigo","year":"2014","unstructured":"Rodrigo R, Libuy M, Feliu F, Hasson D (2014) Polyphenols in disease: from diet to supplements. Curr Pharm Biotechnol 15(4):304\u2013317. https:\/\/doi.org\/10.2174\/138920101504140825113815","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"4167_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: a review of its effects on human health. Foods 6(10):92. https:\/\/doi.org\/10.3390\/foods6100092","journal-title":"Foods"},{"issue":"2","key":"4167_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","volume":"7","author":"A Amalraj","year":"2016","unstructured":"Amalraj A, Pius A, Gopi S, Gopi S (2016) Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2014a review. J Tradit Complement Med 7(2):205\u2013233. https:\/\/doi.org\/10.1016\/j.jtcme.2016.05.005","journal-title":"J Tradit Complement Med"},{"key":"4167_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jnim.2018.05.001","volume":"14","author":"RM Susana","year":"2018","unstructured":"Susana RM, Joyce T, Chaverri JP (2018) Utility of curcumin for the treatment of diabetes mellitus: evidence from preclinical and clinical studies. J Nutr Intermed Metab 14:29\u201341. https:\/\/doi.org\/10.1016\/j.jnim.2018.05.001","journal-title":"J Nutr Intermed Metab"},{"key":"4167_CR27","doi-asserted-by":"publisher","first-page":"01021","DOI":"10.3389\/fphar.2020.01021","volume":"11","author":"J Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, Sestito S, Rapposelli S, Neffe-Skoci\u0144ska K, Zieli\u0144ska D, Salehi B, Setzer WN, Dosoky NS, Taheri Y, El Beyrouthy M, Martorell M, Ostrander EA, Suleria HAR, Cho WC, Maroyi A, Martins N (2020) Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical biotechnological and medicinal applications. Front Pharmacol 11:01021. https:\/\/doi.org\/10.3389\/fphar.2020.01021","journal-title":"Front Pharmacol"},{"key":"4167_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fphar.2018.00548","volume":"9","author":"B Shal","year":"2018","unstructured":"Shal B, Ding W, Ali H, Kim YS, Khan S (2018) Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer\u2019s disease. Front Pharmacol 9:548. https:\/\/doi.org\/10.3389\/fphar.2018.00548","journal-title":"Front Pharmacol"},{"issue":"1","key":"4167_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/molecules27010233","volume":"27","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Rahaman MS, Islam MR, Rahman F, Mithi FM, Alqahtani T, Almikhlafi MA, Alghamdi SQ, Alruwaili AS, Hossain MS, Ahmed M, Das R, Emran TB, Uddin MS (2021) Role of phenolic compounds in human disease: current knowledge and future prospects. Molecules 27(1):233. https:\/\/doi.org\/10.3390\/molecules27010233","journal-title":"Molecules"},{"issue":"2","key":"4167_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2008.11.002","volume":"30","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30(2):85\u201394. https:\/\/doi.org\/10.1016\/j.tips.2008.11.002","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"4167_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1570159X11311040002","volume":"11","author":"WH Lee","year":"2013","unstructured":"Lee WH, Loo CY, Bebawy M, Luk F, Mason RS, Rohanizadeh R (2013) Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 11(4):338\u2013378. https:\/\/doi.org\/10.2174\/1570159X11311040002","journal-title":"Curr Neuropharmacol"},{"issue":"13","key":"4167_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0973-7847.112843","volume":"7","author":"SK Yadav","year":"2013","unstructured":"Yadav SK, Sah AK, Jha RK, Sah P, Shah DK (2013) Turmeric (curcumin) remedies gastroprotective action. Pharmacogn Rev 7(13):42\u201346. https:\/\/doi.org\/10.4103\/0973-7847.112843","journal-title":"Pharmacogn Rev"},{"issue":"10","key":"4167_CR33","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3390\/nu11102376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G (2019) Curcumin and cancer. Nutrients 11(10):2376. https:\/\/doi.org\/10.3390\/nu11102376","journal-title":"Nutrients"},{"issue":"1","key":"4167_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195\u2013218. https:\/\/doi.org\/10.1208\/s12248-012-9432-8","journal-title":"AAPS J"},{"issue":"1","key":"4167_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13048-020-00731-7","volume":"13","author":"MH Pourhanifeh","year":"2020","unstructured":"Pourhanifeh MH, Darvish M, Tabatabaeian J et al (2020) Therapeutic role of curcumin and its novel formulations in gynecological cancers. J Ovarian Res 13(1):130. https:\/\/doi.org\/10.1186\/s13048-020-00731-7","journal-title":"J Ovarian Res"},{"issue":"11","key":"4167_CR36","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1017\/S0007114509993667","volume":"103","author":"J Epstein","year":"2010","unstructured":"Epstein J, Sanderson IR, Macdonald TT (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103(11):1545\u20131557. https:\/\/doi.org\/10.1017\/S0007114509993667","journal-title":"Br J Nutr"},{"issue":"28","key":"4167_CR37","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1080\/10408398.2022.2067827","volume":"63","author":"W Ma","year":"2023","unstructured":"Ma W, Xu D, Zhao L, Yuan M, Cui YL, Li Y (2023) Therapeutic role of curcumin in adult neurogenesis for management of psychiatric and neurological disorders: a scientometric study to an in-depth review. Crit Rev Food Sci Nutr 63(28):9379\u20139391. https:\/\/doi.org\/10.1080\/10408398.2022.2067827","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"4167_CR38","doi-asserted-by":"publisher","first-page":"HC19","DOI":"10.7860\/JCDR\/2014\/9273.4705","volume":"8","author":"A Abidi","year":"2014","unstructured":"Abidi A, Gupta S, Agarwal M, Bhalla HL, Saluja M (2014) Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma. J Clin Diagn Res 8(8):HC19\u2013HC24. https:\/\/doi.org\/10.7860\/JCDR\/2014\/9273.4705","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"4167_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.anai.2016.09.427","volume":"117","author":"S Wu","year":"2016","unstructured":"Wu S, Xiao D (2016) Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol 117(6):697-702.e1. https:\/\/doi.org\/10.1016\/j.anai.2016.09.427","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"4167_CR40","first-page":"21","volume":"95","author":"L Birdane","year":"2016","unstructured":"Birdane L, Cingi C, Muluk NB, San T, Burukoglu D (2016) Evaluation of the efficacy of curcumin in experimentally induced acute sinusitis in rats. Ear Nose Throat J 95(12):21\u201327 (PMID: 27929603)","journal-title":"Ear Nose Throat J"},{"key":"4167_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","volume":"595","author":"GM Cole","year":"2007","unstructured":"Cole GM, Teter B, Frautschy SA (2007) Neuroprotective effects of curcumin. Adv Exp Med Biol 595:197\u2013212. https:\/\/doi.org\/10.1007\/978-0-387-46401-5_8","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4167_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/ERHM.2018.00024","volume":"4","author":"N Seddon","year":"2019","unstructured":"Seddon N, D\u2019Cunha NM, Mellor DD, McKune AJ, Georgousopoulou EN, Panagiotakos DB et al (2019) Effects of curcumin on cognitive function\u2014a systematic review of randomized controlled trials. Explor Res Hypothesis Med. 4(1):1\u201311. https:\/\/doi.org\/10.14218\/ERHM.2018.00024","journal-title":"Explor Res Hypothesis Med."},{"key":"4167_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.669448","volume":"12","author":"LT Marton","year":"2021","unstructured":"Marton LT, Pescinini-E-Salzedas LM, Camargo MEC et al (2021) The effects of curcumin on diabetes mellitus: a systematic review. Front Endocrinol 12:669448. https:\/\/doi.org\/10.3389\/fendo.2021.669448","journal-title":"Front Endocrinol"},{"key":"4167_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.572533","volume":"11","author":"T Ramaholimihaso","year":"2020","unstructured":"Ramaholimihaso T, Bouazzaoui F, Kaladjian A (2020) Curcumin in depression: potential mechanisms of action and current evidence\u2014a narrative review. Front Psychiatry 11:572533. https:\/\/doi.org\/10.3389\/fpsyt.2020.572533","journal-title":"Front Psychiatry"},{"issue":"20","key":"4167_CR45","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.3390\/ijms222011248","volume":"22","author":"EE Nebrisi","year":"2021","unstructured":"Nebrisi EE (2021) Neuroprotective activities of curcumin in Parkinson\u2019s disease: a review of the literature. Int J Mol Sci 22(20):11248. https:\/\/doi.org\/10.3390\/ijms222011248","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4167_CR46","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/ijms19061637","volume":"19","author":"P Maiti","year":"2018","unstructured":"Maiti P, Dunbar GL (2018) Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases. Int J Mol Sci 19(6):1637. https:\/\/doi.org\/10.3390\/ijms19061637","journal-title":"Int J Mol Sci"},{"key":"4167_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fphar.2020.00487","volume":"11","author":"A Karthikeyan","year":"2020","unstructured":"Karthikeyan A, Senthil N, Min T (2020) Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol 11:487. https:\/\/doi.org\/10.3389\/fphar.2020.00487","journal-title":"Front Pharmacol"},{"key":"4167_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.767493","volume":"13","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Mishra AK, Peer GDG et al (2021) The interplay of the unfolded protein response in neurodegenerative diseases: a therapeutic role of curcumin. Front Aging Neurosci 13:767493. https:\/\/doi.org\/10.3389\/fnagi.2021.767493","journal-title":"Front Aging Neurosci"},{"key":"4167_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.fct.2015.05.022","volume":"83","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Banerjee S, Sil PC (2015) The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update. Food Chem Toxicol 83:111\u2013124. https:\/\/doi.org\/10.1016\/j.fct.2015.05.022","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4167_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/molecules27010236","volume":"27","author":"T Benameur","year":"2021","unstructured":"Benameur T, Giacomucci G, Panaro MA et al (2021) New promising therapeutic avenues of curcumin in brain diseases. Molecules 27(1):236. https:\/\/doi.org\/10.3390\/molecules27010236","journal-title":"Molecules"},{"issue":"6","key":"4167_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15407\/biotech8.06.048","volume":"8","author":"VV Sokolik","year":"2015","unstructured":"Sokolik VV, Shulga SM (2015) Effect of curcumin liposomal form on angiotensin converting activity, cytokines and cognitive characteristics of the rats with Alzheimer\u2019s disease model. Biotechnologia Acta 8(6):48\u201356. https:\/\/doi.org\/10.15407\/biotech8.06.048","journal-title":"Biotechnologia Acta"},{"issue":"2","key":"4167_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12263-011-0222-1","volume":"6","author":"S Reuter","year":"2011","unstructured":"Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB (2011) Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 6(2):93\u2013108. https:\/\/doi.org\/10.1007\/s12263-011-0222-1","journal-title":"Genes Nutr"},{"issue":"2","key":"4167_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/nu13020332","volume":"13","author":"K Fabianowska-Majewska","year":"2021","unstructured":"Fabianowska-Majewska K, Kaufman-Szymczyk A, Szymanska-Kolba A, Jakubik J, Majewski G, Lubecka K (2021) Curcumin from turmeric rhizome: a potential modulator of DNA methylation machinery in breast cancer inhibition. Nutrients 13(2):332. https:\/\/doi.org\/10.3390\/nu13020332","journal-title":"Nutrients"},{"key":"4167_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fgene.2019.00514","volume":"10","author":"FU Hassan","year":"2019","unstructured":"Hassan FU, Rehman MS, Khan MS et al (2019) Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front Genet 10:514. https:\/\/doi.org\/10.3389\/fgene.2019.00514","journal-title":"Front Genet"},{"issue":"9","key":"4167_CR55","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/mnfr.201300201","volume":"57","author":"MH Teiten","year":"2013","unstructured":"Teiten MH, Dicato M, Diederich M (2013) Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 57(9):1619\u20131629. https:\/\/doi.org\/10.1002\/mnfr.201300201","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"4167_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40495-015-0018-x","volume":"1","author":"SS Boyanapalli","year":"2015","unstructured":"Boyanapalli SS, Kong AT (2015) \u201cCurcumin, the King of Spices\u201d: epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Curr Pharmacol Rep 1(2):129\u2013139. https:\/\/doi.org\/10.1007\/s40495-015-0018-x","journal-title":"Curr Pharmacol Rep"},{"key":"4167_CR57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2174\/1570159x14666160104142223","volume":"6","author":"VP Dadhania","year":"2016","unstructured":"Dadhania VP, Trivedi PP, Vikram A, Tripathi DN (2016) Nutraceuticals against neurodegeneration: a mechanistic insight. Curr Neuropharmacol 6:627\u2013640. https:\/\/doi.org\/10.2174\/1570159x14666160104142223","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"4167_CR58","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.3390\/ijms22084045","volume":"22","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur G, Sehgal A et al (2021) Elucidating the multi-targeted role of nutraceuticals: a complementary therapy to starve neurodegenerative diseases. Int J Mol Sci 22(8):4045. https:\/\/doi.org\/10.3390\/ijms22084045","journal-title":"Int J Mol Sci"},{"issue":"21","key":"4167_CR59","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003\u20132014. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"issue":"1","key":"4167_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40478-021-01224-4","volume":"9","author":"P Jadiya","year":"2021","unstructured":"Jadiya P, Garbincius JF, Elrod JW (2021) Reappraisal of metabolic dysfunction in neurodegeneration: focus on mitochondrial function and calcium signaling. Acta Neuropathol Commun 9(1):124. https:\/\/doi.org\/10.1186\/s40478-021-01224-4","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4167_CR61","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"4167_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/cm.20388","volume":"66","author":"JR Bamburg","year":"2009","unstructured":"Bamburg JR, Bloom GS (2009) Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 66(8):635\u2013649. https:\/\/doi.org\/10.1002\/cm.20388","journal-title":"Cell Motil Cytoskeleton"},{"issue":"1","key":"4167_CR63","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener 15(1):40. https:\/\/doi.org\/10.1186\/s13024-020-00391-7","journal-title":"Mol Neurodegener"},{"issue":"6","key":"4167_CR64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909. https:\/\/doi.org\/10.1016\/S0896-6273(03)00568-3","journal-title":"Neuron"},{"issue":"15","key":"4167_CR65","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1111\/jcmm.15508","volume":"24","author":"A Zhao","year":"2020","unstructured":"Zhao A, Li Y, Niu M et al (2020) SNPs in SNCA, MCCC1, DLG2, GBF1 and MBNL2 are associated with Parkinson\u2019s disease in southern Chinese population. J Cell Mol Med 24(15):8744\u20138752. https:\/\/doi.org\/10.1111\/jcmm.15508","journal-title":"J Cell Mol Med"},{"key":"4167_CR66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41598-020-79990-9","volume":"11","author":"M Langmyhr","year":"2021","unstructured":"Langmyhr M, Henriksen SP, Cappelletti C et al (2021) Allele-specific expression of Parkinson\u2019s disease susceptibility genes in human brain. Sci Rep 11:504. https:\/\/doi.org\/10.1038\/s41598-020-79990-9","journal-title":"Sci Rep"},{"key":"4167_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.503477","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Ke S, Qiao Z et al (2021) Interactions between glycogen synthase kinase-3\u03b2 gene polymorphisms, negative life events, and susceptibility to major depressive disorder in a Chinese population. Front Psychiatry 11:503477. https:\/\/doi.org\/10.3389\/fpsyt.2020.503477","journal-title":"Front Psychiatry"},{"issue":"4","key":"4167_CR68","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ana.21476","volume":"64","author":"JB Kwok","year":"2008","unstructured":"Kwok JB, Loy CT, Hamilton G et al (2008) Glycogen synthase kinase-3beta and tau genes interact in Alzheimer\u2019s disease. Ann Neurol 64(4):446\u2013454. https:\/\/doi.org\/10.1002\/ana.21476","journal-title":"Ann Neurol"},{"issue":"1","key":"4167_CR69","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/ijmm.2019.4198","volume":"44","author":"J Chen","year":"2019","unstructured":"Chen J, Long Z, Li Y, Luo M, Luo S, He G (2019) Alteration of the Wnt\/GSK3\u03b2\/\u03b2catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer\u2019s disease model. Int J Mol Med 44(1):313\u2013323. https:\/\/doi.org\/10.3892\/ijmm.2019.4198","journal-title":"Int J Mol Med"},{"issue":"1","key":"4167_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41531-021-00196-5","volume":"7","author":"CC Pedersen","year":"2021","unstructured":"Pedersen CC, Lange J, F\u00f8rland MGG, Macleod AD, Alves G, Maple-Gr\u00f8dem J (2021) A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson\u2019s disease. NPJ Parkinson\u2019s disease 7(1):54. https:\/\/doi.org\/10.1038\/s41531-021-00196-5","journal-title":"NPJ Parkinson\u2019s disease"},{"issue":"1","key":"4167_CR71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","volume":"45","author":"B DaRocha-Souto","year":"2012","unstructured":"DaRocha-Souto B, Coma M, P\u00e9rez-Nievas BG et al (2012) Activation of glycogen synthase kinase-3 beta mediates \u03b2-amyloid induced neuritic damage in Alzheimer\u2019s disease. Neurobiol Dis 45(1):425\u2013437. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.002","journal-title":"Neurobiol Dis"},{"issue":"Pt 7","key":"4167_CR72","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/brain\/awn323","volume":"132","author":"F Simunovic","year":"2009","unstructured":"Simunovic F, Yi M, Wang Y et al (2009) Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson\u2019s disease pathology. Brain 132(Pt 7):1795\u20131809. https:\/\/doi.org\/10.1093\/brain\/awn323","journal-title":"Brain"},{"issue":"8","key":"4167_CR73","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.3390\/ijms21083006","volume":"21","author":"E Jia","year":"2020","unstructured":"Jia E, Zhou Y, Liu Z et al (2020) Transcriptomic profiling of circular RNA in different brain regions of Parkinson\u2019s disease in a mouse model. Int J Mol Sci 21(8):3006. https:\/\/doi.org\/10.3390\/ijms21083006","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4167_CR74","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4161\/cbt.3.2.614","volume":"3","author":"GS Wu","year":"2004","unstructured":"Wu GS (2004) The functional interactions between the MAPK and p53 signaling pathways. Cancer Biol Ther 3(2):156\u2013161. https:\/\/doi.org\/10.4161\/cbt.3.2.614","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"4167_CR75","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12640-016-9626-4","volume":"30","author":"F Montarolo","year":"2016","unstructured":"Montarolo F, Perga S, Martire S et al (2016) Altered NR4A subfamily gene expression level in peripheral blood of Parkinson\u2019s and Alzheimer\u2019s disease patients. Neurotox Res 30(3):338\u2013344. https:\/\/doi.org\/10.1007\/s12640-016-9626-4","journal-title":"Neurotox Res"},{"issue":"3","key":"4167_CR76","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jnc.14147","volume":"143","author":"RB Mythri","year":"2017","unstructured":"Mythri RB, Raghunath NR, Narwade SC, Pandareesh MDR, Sabitha KR, Aiyaz M, Srinivas Bharath MM (2017) Manganese-and 1-methyl-4-phenylpyridinium-induced neurotoxicity display differences in morphological, electrophysiological and genome-wide alterations: implications for idiopathic Parkinson\u2019s disease. J Neurochem 143(3):334\u2013358. https:\/\/doi.org\/10.1111\/jnc.14147","journal-title":"J Neurochem"},{"key":"4167_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2014.11.002","volume":"74","author":"E Glaab","year":"2015","unstructured":"Glaab E, Schneider R (2015) Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson\u2019s disease. Neurobiol Dis 74:1\u201313. https:\/\/doi.org\/10.1016\/j.nbd.2014.11.002","journal-title":"Neurobiol Dis"},{"issue":"10","key":"4167_CR78","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.3390\/ijms21103517","volume":"21","author":"E Bagyinszky","year":"2020","unstructured":"Bagyinszky E, Giau VV, An SA (2020) Transcriptomics in Alzheimer\u2019s disease: aspects and challenges. Int J Mol Sci 21(10):3517. https:\/\/doi.org\/10.3390\/ijms21103517","journal-title":"Int J Mol Sci"},{"key":"4167_CR79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","volume":"8","author":"M Wang","year":"2016","unstructured":"Wang M, Roussos P, McKenzie A et al (2016) Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease. Genome Med 8:104. https:\/\/doi.org\/10.1186\/s13073-016-0355-3","journal-title":"Genome Med"},{"key":"4167_CR80","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12640-019-00061-7","volume":"36","author":"P Belenguer","year":"2019","unstructured":"Belenguer P, Duarte JM, Schuck PF, Ferreira GC (2019) Mitochondria and the brain: bioenergetics and beyond. Neurotox Res 36:219\u2013238. https:\/\/doi.org\/10.1007\/s12640-019-00061-7","journal-title":"Neurotox Res"},{"issue":"9","key":"4167_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.688789","volume":"27","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang X, Liu C, Liu Q, Chai H, Luo Y, Li S (2021) Role of mitochondria in neurodegenerative diseases: from an epigenetic perspective. Front Cell Dev Biol 27(9):688789. https:\/\/doi.org\/10.3389\/fcell.2021.688789","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"4167_CR82","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1515\/tjb-2019-0255","volume":"44","author":"AY Abramov","year":"2019","unstructured":"Abramov AY, Angelova PR (2019) Mitochondrial dysfunction and energy deprivation in the mechanism of neurodegeneration. Turk J Biochem 44(6):723\u2013729. https:\/\/doi.org\/10.1515\/tjb-2019-0255","journal-title":"Turk J Biochem"},{"key":"4167_CR83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/JEN.S39887","volume":"10","author":"TF Beckhauser","year":"2016","unstructured":"Beckhauser TF, Francis-Oliveira J, De Pasquale R (2016) Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity. J Exp Neurosci 10:23\u201348. https:\/\/doi.org\/10.4137\/JEN.S39887","journal-title":"J Exp Neurosci"},{"issue":"2","key":"4167_CR84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antiox12020517","volume":"12","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Damian-Holsinger RM (2023) Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants 12(2):517. https:\/\/doi.org\/10.3390\/antiox12020517","journal-title":"Antioxidants"},{"key":"4167_CR85","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 57:1105\u20131121. https:\/\/doi.org\/10.3233\/JAD-161088","journal-title":"J Alzheimers Dis"},{"key":"4167_CR86","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet 20:2495\u20132509. https:\/\/doi.org\/10.1093\/hmg\/ddr139","journal-title":"Hum Mol Genet"},{"key":"4167_CR87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-131715","volume":"40","author":"AC Rice","year":"2014","unstructured":"Rice AC, Keeney PM, Algarzae NK, Ladd AC, Thomas RR, Bennett JPJ (2014) Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer\u2019s disease hippocampi. J Alzheimers Dis 40:319\u2013330. https:\/\/doi.org\/10.3233\/JAD-131715","journal-title":"J Alzheimers Dis"},{"key":"4167_CR88","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio Compagnoni","year":"2020","unstructured":"Monzio Compagnoni G, Di Fonzo A, Corti S, Comi GP, Bresolin N, Masliah E (2020) The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Mol Neurobiol 57:2959\u20132980. https:\/\/doi.org\/10.1007\/s12035-020-01926-1","journal-title":"Mol Neurobiol"},{"key":"4167_CR89","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.410440612","volume":"44","author":"N Hattori","year":"1998","unstructured":"Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 44:935\u2013941. https:\/\/doi.org\/10.1002\/ana.410440612","journal-title":"Ann Neurol"},{"key":"4167_CR90","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonz\u00e1lez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284","journal-title":"Science"},{"key":"4167_CR91","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787. https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"key":"4167_CR92","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2015.5885","author":"M Orsini","year":"2015","unstructured":"Orsini M, Oliveira AB, Nascimento OJ, Reis CHM, Leite MAA, de Souza JA, Pupe C, de Souza OG, Bastos VH, de Freitas MR (2015) Amyotrophic lateral sclerosis: new perpectives and update. Neurol Int. https:\/\/doi.org\/10.4081\/ni.2015.5885","journal-title":"Neurol Int"},{"key":"4167_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052","journal-title":"Neurosci Lett"},{"key":"4167_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-1-19","volume":"1","author":"S Li","year":"2006","unstructured":"Li S, Li XJ (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 1:19. https:\/\/doi.org\/10.1186\/1750-1326-1-19","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4167_CR95","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1038\/s41467-019-10101-7","volume":"10","author":"P Li","year":"2019","unstructured":"Li P, Marshall L, Oh G et al (2019) Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer\u2019s disease pathology and cognitive symptoms. Nat Commun 10(1):2246. https:\/\/doi.org\/10.1038\/s41467-019-10101-7","journal-title":"Nat Commun"},{"key":"4167_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2021.01.016","author":"P Ghosh","year":"2021","unstructured":"Ghosh P, Saadat A (2021) Neurodegeneration and epigenetics: a review. Neurologia. https:\/\/doi.org\/10.1016\/j.nrl.2021.01.016","journal-title":"Neurologia"},{"issue":"2","key":"4167_CR97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/jhg.2014.110","volume":"60","author":"Z Yu","year":"2015","unstructured":"Yu Z, Wang T, Xu J et al (2015) Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson\u2019s disease. J Hum Genet 60(2):85\u201390. https:\/\/doi.org\/10.1038\/jhg.2014.110","journal-title":"J Hum Genet"},{"issue":"11","key":"4167_CR98","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/01616412.2017.1368141","volume":"39","author":"IE Eryilmaz","year":"2017","unstructured":"Eryilmaz IE, Cecener G, Erer S et al (2017) Epigenetic approach to early-onset Parkinson\u2019s disease: low methylation status of SNCA and PARK2 promoter regions. Neurol Res 39(11):965\u2013972. https:\/\/doi.org\/10.1080\/01616412.2017.1368141","journal-title":"Neurol Res"},{"issue":"2","key":"4167_CR99","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","volume":"186","author":"M Blanch","year":"2016","unstructured":"Blanch M, Mosquera JL, Ansoleaga B, Ferrer I, Barrachina M (2016) Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease. Am J Pathol 186(2):385\u2013397. https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.004","journal-title":"Am J Pathol"},{"issue":"3","key":"4167_CR100","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.nbd.2008.05.013","volume":"31","author":"XW Zhou","year":"2008","unstructured":"Zhou XW, Gustafsson JA, Tanila H et al (2008) Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis 31(3):386\u2013394. https:\/\/doi.org\/10.1016\/j.nbd.2008.05.013","journal-title":"Neurobiol Dis"},{"issue":"3","key":"4167_CR101","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","volume":"47","author":"E Alberdi","year":"2010","unstructured":"Alberdi E, S\u00e1nchez-G\u00f3mez MV, Cavaliere F et al (2010) Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47(3):264\u2013272. https:\/\/doi.org\/10.1016\/j.ceca.2009.12.010","journal-title":"Cell Calcium"},{"issue":"1","key":"4167_CR102","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1073\/pnas.1318807111","volume":"111","author":"KV Kuchibhotla","year":"2014","unstructured":"Kuchibhotla KV, Wegmann S, Kopeikina KJ et al (2014) Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci U S A 111(1):510\u2013514. https:\/\/doi.org\/10.1073\/pnas.1318807111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5512","key":"4167_CR103","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF et al (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291(5512):2423\u20132428. https:\/\/doi.org\/10.1126\/science.1056784","journal-title":"Science"},{"issue":"5","key":"4167_CR104","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-017-1732-8","volume":"134","author":"J Lee","year":"2017","unstructured":"Lee J, Hwang YJ, Kim Y et al (2017) Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington\u2019s disease. Acta Neuropathol 134(5):729\u2013748. https:\/\/doi.org\/10.1007\/s00401-017-1732-8","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"4167_CR105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","volume":"667","author":"L Migliore","year":"2009","unstructured":"Migliore L, Copped\u00e8 F (2009) Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 667(1\u20132):82\u201397. https:\/\/doi.org\/10.1016\/j.mrfmmm.2008.10.011","journal-title":"Mutat Res"},{"issue":"11","key":"4167_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto L, Takuma H, Tamaoka A et al (2010) CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease. PLoS ONE 5(11):e15522. https:\/\/doi.org\/10.1371\/journal.pone.0015522","journal-title":"PLoS ONE"},{"key":"4167_CR107","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cells13040296","volume":"13","author":"LD Skou","year":"2024","unstructured":"Skou LD, Johansen SK, Okarmus J, Meyer M (2024) Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease. Cells 13:296. https:\/\/doi.org\/10.3390\/cells13040296","journal-title":"Cells"},{"issue":"18","key":"4167_CR108","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci 30(18):6355\u20136359. https:\/\/doi.org\/10.1523\/JNEUROSCI.6119-09.2010","journal-title":"J Neurosci"},{"issue":"11","key":"4167_CR109","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","volume":"286","author":"P Desplats","year":"2011","unstructured":"Desplats P, Spencer B, Coffee E et al (2011) Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem 286(11):9031\u20139037. https:\/\/doi.org\/10.1074\/jbc.C110.212589","journal-title":"J Biol Chem"},{"issue":"9","key":"4167_CR110","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/00207454.2011.580866","volume":"121","author":"M Cai","year":"2011","unstructured":"Cai M, Tian J, Zhao GH, Luo W, Zhang BR (2011) Study of methylation levels of parkin gene promoter in Parkinson\u2019s disease patients. Int J Neurosci 121(9):497\u2013502. https:\/\/doi.org\/10.3109\/00207454.2011.580866","journal-title":"Int J Neurosci"},{"issue":"28","key":"4167_CR111","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1021\/bi0341152","volume":"42","author":"J Goers","year":"2003","unstructured":"Goers J, Manning-Bog AB, McCormack AL et al (2003) Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 42(28):8465\u20138471. https:\/\/doi.org\/10.1021\/bi0341152","journal-title":"Biochemistry"},{"issue":"5842","key":"4167_CR112","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, Inoue K, Ishii J et al (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317(5842):1220\u20131224. https:\/\/doi.org\/10.1126\/science.1140481","journal-title":"Science"},{"issue":"3","key":"4167_CR113","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.nbd.2005.12.021","volume":"22","author":"S Vartiainen","year":"2006","unstructured":"Vartiainen S, Pehkonen P, Lakso M, Nass R, Wong G (2006) Identification of gene expression changes in transgenic C. elegans overexpressing human alpha-synuclein. Neurobiol Dis 22(3):477\u2013486. https:\/\/doi.org\/10.1016\/j.nbd.2005.12.021","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4167_CR114","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12031-009-9325-1","volume":"41","author":"S Asikainen","year":"2010","unstructured":"Asikainen S, Rudgalvyte M, Heikkinen L et al (2010) Global microRNA expression profiling of Caenorhabditis elegans Parkinson\u2019s disease models. J Mol Neurosci 41(1):210\u2013218. https:\/\/doi.org\/10.1007\/s12031-009-9325-1","journal-title":"J Mol Neurosci"},{"issue":"24","key":"4167_CR115","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"issue":"7243","key":"4167_CR116","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55\u201360. https:\/\/doi.org\/10.1038\/nature07925","journal-title":"Nature"},{"key":"4167_CR117","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fgene.2018.00579","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Jiao B, Shen L (2018) The epigenetics of Alzheimer\u2019s disease: factors and therapeutic implications. Front Genet 9:579. https:\/\/doi.org\/10.3389\/fgene.2018.00579","journal-title":"Front Genet"},{"issue":"5","key":"4167_CR118","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","volume":"106","author":"H Ding","year":"2008","unstructured":"Ding H, Dolan PJ, Johnson GV (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106(5):2119\u20132130. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05564.x","journal-title":"J Neurochem"},{"issue":"1","key":"4167_CR119","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02686117","volume":"31","author":"RS Broide","year":"2007","unstructured":"Broide RS, Redwine JM, Aftahi N et al (2007) Distribution of histone deacetylases 1\u201311 in the rat brain. J Mol Neurosci 31(1):47\u201358. https:\/\/doi.org\/10.1007\/BF02686117","journal-title":"J Mol Neurosci"},{"issue":"4","key":"4167_CR120","doi-asserted-by":"publisher","first-page":"775","DOI":"10.18632\/aging.101427","volume":"10","author":"Z Wang","year":"2018","unstructured":"Wang Z, Xu P, Chen B et al (2018) Identifying circRNA-associated-ceRNA networks in the hippocampus of A\u03b21\u201342-induced Alzheimer\u2019s disease-like rats using microarray analysis. Aging (Albany NY). 10(4):775\u2013788. https:\/\/doi.org\/10.18632\/aging.101427","journal-title":"Aging (Albany NY)."},{"issue":"2","key":"4167_CR121","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.23588","volume":"72","author":"ST Lee","year":"2012","unstructured":"Lee ST, Chu K, Jung KH et al (2012) miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol 72(2):269\u2013277. https:\/\/doi.org\/10.1002\/ana.23588","journal-title":"Ann Neurol"},{"issue":"8","key":"4167_CR122","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.neurobiolaging.2014.02.002","volume":"35","author":"D Condliffe","year":"2014","unstructured":"Condliffe D, Wong A, Troakes C et al (2014) Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer\u2019s disease brain. Neurobiol Aging 35(8):1850\u20131854. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.02.002","journal-title":"Neurobiol Aging"},{"issue":"10","key":"4167_CR123","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series. EMBO Rep 5(10):958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250","journal-title":"EMBO Rep"},{"issue":"50","key":"4167_CR124","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW et al (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci U S A 103(50):19176\u201319181. https:\/\/doi.org\/10.1073\/pnas.0606373103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4167_CR125","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4103\/1673-5374.235029","volume":"13","author":"N Zsindely","year":"2018","unstructured":"Zsindely N, Bodai L (2018) Histone methylation in Huntington\u2019s disease: are bivalent promoters the critical targets? Neural Regen Res 13(7):1191\u20131192. https:\/\/doi.org\/10.4103\/1673-5374.235029","journal-title":"Neural Regen Res"},{"issue":"6","key":"4167_CR126","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"16","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 16(6):171. https:\/\/doi.org\/10.4103\/2152-7806.169561","journal-title":"Surg Neurol Int"},{"key":"4167_CR127","doi-asserted-by":"publisher","first-page":"263310552095730","DOI":"10.1177\/2633105520957302","volume":"15","author":"ML Floare","year":"2020","unstructured":"Floare ML, Allen SP (2020) Why TDP-43? Why not? Mechanisms of metabolic dysfunction in amyotrophic lateral sclerosis. Neurosci Insights. 15:2633105520957302. https:\/\/doi.org\/10.1177\/2633105520957302","journal-title":"Neurosci Insights."},{"key":"4167_CR128","doi-asserted-by":"publisher","first-page":"1017364","DOI":"10.3389\/fphar.2022.1017364","volume":"13","author":"E Parrella","year":"2022","unstructured":"Parrella E, Porrini V, Scambi I, Gennari MM, Gussago C, Bankole O, Benarese M, Mariotti R, Pizzi M (2022) Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. Front Pharmacol 13:1017364. https:\/\/doi.org\/10.3389\/fphar.2022.1017364","journal-title":"Front Pharmacol"},{"issue":"6","key":"4167_CR129","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bph.15217","volume":"178","author":"YE Klingl","year":"2021","unstructured":"Klingl YE, Pakravan D, Van Den Bosch L (2021) Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis. Br J Pharmacol 178(6):1353\u20131372. https:\/\/doi.org\/10.1111\/bph.15217","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4167_CR130","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","volume":"7","author":"E Rossaert","year":"2019","unstructured":"Rossaert E, Pollari E, Jaspers T, Van Helleputte L, Jarpe M, Van Damme P, De Bock K, Moisse M, Van Den Bosch L (2019) Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun 7(1):107. https:\/\/doi.org\/10.1186\/s40478-019-0750-2","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"4167_CR131","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2022) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol 20(1):158\u2013178. https:\/\/doi.org\/10.2174\/1570159X19666210609160017","journal-title":"Curr Neuropharmacol"},{"key":"4167_CR132","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3389\/fnins.2020.00679","volume":"14","author":"ML Cali\u00f3","year":"2020","unstructured":"Cali\u00f3 ML, Henriques E, Siena A, Bertoncini CRA, Gil-Mohapel J, Rosenstock TR (2020) Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front Neurosci 14:679. https:\/\/doi.org\/10.3389\/fnins.2020.00679","journal-title":"Front Neurosci"},{"key":"4167_CR133","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362. https:\/\/doi.org\/10.1038\/362059a0","journal-title":"Nature"},{"key":"4167_CR134","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/17482960601149160","volume":"82","author":"N Oates","year":"2007","unstructured":"Oates N, Pamphlett R (2007) An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph Lateral Scler 82:83\u201386. https:\/\/doi.org\/10.1080\/17482960601149160","journal-title":"Amyotroph Lateral Scler"},{"key":"4167_CR135","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/glia.20922","volume":"58","author":"Y Yang","year":"2010","unstructured":"Yang Y, Gozen O, Vidensky S, Robinson MB, Rothstein JD (2010) Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia 58:277\u2013286. https:\/\/doi.org\/10.1002\/glia.20922","journal-title":"Glia"},{"key":"4167_CR136","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/21678421.2013.851247","volume":"15","author":"L Tremolizzo","year":"2014","unstructured":"Tremolizzo L, Messina P, Conti E, Sala G, Cecchi M, Airoldi L et al (2014) Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph Lateral Scler Frontotemporal Degener 15:98\u2013105. https:\/\/doi.org\/10.3109\/21678421.2013.851247","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"21","key":"4167_CR137","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3390\/cells11213448","volume":"11","author":"LJ Martin","year":"2022","unstructured":"Martin LJ, Adams DA, Niedzwiecki MV, Wong M (2022) Aberrant DNA and RNA methylation occur in spinal cord and skeletal muscle of human SOD1 mouse models of ALS and in human ALS: targeting DNA methylation is therapeutic. Cells 11(21):3448. https:\/\/doi.org\/10.3390\/cells11213448","journal-title":"Cells"},{"key":"4167_CR138","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","volume":"204","author":"SA Bennett","year":"2019","unstructured":"Bennett SA, Tanaz R, Cobos SN, Torrente MP (2019) Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Transl Res 204:19\u201330. https:\/\/doi.org\/10.1016\/j.trsl.2018.10.002","journal-title":"Transl Res"},{"key":"4167_CR139","doi-asserted-by":"publisher","first-page":"8413496","DOI":"10.1155\/2018\/8413496","volume":"2018","author":"SC Ling","year":"2018","unstructured":"Ling SC (2018) Synaptic paths to neurodegeneration: the emerging role of TDP-43 and FUS in synaptic functions. Neural Plast 2018:8413496. https:\/\/doi.org\/10.1155\/2018\/8413496","journal-title":"Neural Plast"},{"key":"4167_CR140","doi-asserted-by":"publisher","first-page":"9538","DOI":"10.1038\/s41598-017-10161-z","volume":"7","author":"L Di Pietro","year":"2017","unstructured":"Di Pietro L, Baranzini M, Berardinelli MG et al (2017) Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci Rep 7:9538. https:\/\/doi.org\/10.1038\/s41598-017-10161-z","journal-title":"Sci Rep"},{"issue":"29","key":"4167_CR141","first-page":"25","volume":"6","author":"M Gacias","year":"2014","unstructured":"Gacias M, Casaccia P (2014) Epigenetic mechanisms in multiple sclerosis. Rev Esp Escler Mult 6(29):25\u201335","journal-title":"Rev Esp Escler Mult"},{"issue":"1\u20132","key":"4167_CR142","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jns.2009.12.018","volume":"290","author":"T Liggett","year":"2010","unstructured":"Liggett T, Melnikov A, Tilwalli S, Yi Q, Chen H, Replogle C et al (2010) Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci 290(1\u20132):16\u201321. https:\/\/doi.org\/10.1016\/j.jns.2009.12.018","journal-title":"J Neurol Sci"},{"key":"4167_CR143","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1038\/s41598-017-08623-5","volume":"7","author":"AM Chomyk","year":"2017","unstructured":"Chomyk AM, Volsko C, Tripathi A et al (2017) DNA methylation in demyelinated multiple sclerosis hippocampus. Sci Rep 7:8696. https:\/\/doi.org\/10.1038\/s41598-017-08623-5","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"4167_CR144","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2012.03.003","volume":"246","author":"C Kumagai","year":"2012","unstructured":"Kumagai C, Kalman B, Middleton FA, Vyshkina T, Massa PT (2012) Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol 246(1\u20132):51\u201357. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.003","journal-title":"J Neuroimmunol"},{"key":"4167_CR145","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12017-014-8298-6","volume":"17","author":"C\u0130 K\u00fc\u00e7\u00fckali","year":"2015","unstructured":"K\u00fc\u00e7\u00fckali C\u0130, K\u00fcrt\u00fcnc\u00fc M, \u00c7oban A, \u00c7ebi M, T\u00fcz\u00fcn E (2015) Epigenetics of multiple sclerosis: an updated review. Neuromol Med 17:83\u201396. https:\/\/doi.org\/10.1007\/s12017-014-8298-6","journal-title":"Neuromol Med"},{"issue":"4","key":"4167_CR146","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/ijms25042255","volume":"25","author":"GL Cipriano","year":"2024","unstructured":"Cipriano GL, Schepici G, Mazzon E, Anchesi I (2024) Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways. Int J Mol Sci 25(4):2255. https:\/\/doi.org\/10.3390\/ijms25042255","journal-title":"Int J Mol Sci"},{"key":"4167_CR147","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4049\/jimmunol.2200478","volume":"210","author":"JW Thompson","year":"2023","unstructured":"Thompson JW, Hu R, Huffaker TB, Ramstead AG, Ekiz HA, Bauer KM, Tang WW, Ghazaryan A, Round JL, Fujinami RS et al (2023) MicroRNA-155 plays selective cell-intrinsic roles in brain-infiltrating immune cell populations during neuroinflammation. J Immunol 210:926\u2013934. https:\/\/doi.org\/10.4049\/jimmunol.2200478","journal-title":"J Immunol"},{"issue":"6","key":"4167_CR148","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/107385841138546","volume":"17","author":"NZ Lax","year":"2011","unstructured":"Lax NZ, Turnbull DM, Reeve AK (2011) Mitochondrial mutations: newly discovered players in neuronal degeneration. Neuroscientist 17(6):645\u2013658. https:\/\/doi.org\/10.1177\/107385841138546","journal-title":"Neuroscientist"},{"issue":"2","key":"4167_CR149","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4103\/1673-5374.379045","volume":"19","author":"F Copped\u00e8","year":"2024","unstructured":"Copped\u00e8 F (2024) Mitochondrial DNA methylation and mitochondria-related epigenetics in neurodegeneration. Neural Regen Res 19(2):405\u2013406. https:\/\/doi.org\/10.4103\/1673-5374.379045","journal-title":"Neural Regen Res"},{"key":"4167_CR150","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fendo.2019.00086","volume":"10","author":"F Copped\u00e8","year":"2019","unstructured":"Copped\u00e8 F, Stoccoro A (2019) Mitoepigenetics and neurodegenerative diseases. Front Endocrinol (Lausanne) 10:86. https:\/\/doi.org\/10.3389\/fendo.2019.00086","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4167_CR151","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3389\/.2020.00679","volume":"14","author":"ML Cali\u00f3","year":"2020","unstructured":"Cali\u00f3 ML, Henriques E, Siena A, Bertoncini CR, Gil-Mohapel J, Rosenstock TR (2020) Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment. Front Neurosci 14:679. https:\/\/doi.org\/10.3389\/.2020.00679","journal-title":"Front Neurosci"},{"key":"4167_CR152","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","volume":"186","author":"M Blanch","year":"2016","unstructured":"Blanch M, Mosquera JL, Ansoleaga B, Ferrer I, Barrachina M (2016) Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease. Am J Pathol 186:385\u2013397. https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.004","journal-title":"Am J Pathol"},{"key":"4167_CR153","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2019.09.094","volume":"520","author":"Y Xu","year":"2019","unstructured":"Xu Y, Xu L, Han M, Liu X, Li F, Zhou X, Wang Y, Bi J (2019) Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP\/PS1 transgenic mouse model of Alzheimer disease. Biochem Biophys Res Commun 520:41\u201346. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.094","journal-title":"Biochem Biophys Res Commun"},{"key":"4167_CR154","doi-asserted-by":"publisher","first-page":"1059120","DOI":"10.3389\/fendo.2022.1059120","volume":"13","author":"M Devall","year":"2022","unstructured":"Devall M, Soanes DM, Smith AR, Dempster EL, Smith RG, Burrage J, Iatrou A, Hannon E, Troakes C, Moore K, O\u2019Neill P, Al-Sarraj S, Schalkwyk L, Mill J, Weedon M, Lunnon K (2022) Genome-wide characterization of mitochondrial DNA methylation in human brain. Front Endocrinol (Lausanne) 13:1059120. https:\/\/doi.org\/10.3389\/fendo.2022.1059120","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4167_CR155","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cells1205074","volume":"12","author":"J Rivera","year":"2023","unstructured":"Rivera J, Gangwani L, Kumar S (2023) Mitochondria localized microRNAs: An unexplored miRNA niche in Alzheimer\u2019s disease and aging. Cells 12(5):742. https:\/\/doi.org\/10.3390\/cells1205074","journal-title":"Cells"},{"issue":"3","key":"4167_CR156","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/1673-5374.26604","volume":"15","author":"A Popa-Wagner","year":"2020","unstructured":"Popa-Wagner A, Dumitrascu DI, Capitanescu B, Petcu EB, Surugiu R, Fang WH, Dumbrava DA (2020) Dietary habits, lifestyle factors and neurodegenerative diseases. Neural Regen Res 15(3):394\u2013400. https:\/\/doi.org\/10.4103\/1673-5374.26604","journal-title":"Neural Regen Res"},{"key":"4167_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.01.014","volume":"57","author":"R Gabbianelli","year":"2018","unstructured":"Gabbianelli R, Damiani E (2018) Epigenetics and neurodegeneration: role of early-life nutrition. J Nutr Biochem 57:1\u201313. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.01.014","journal-title":"J Nutr Biochem"},{"key":"4167_CR158","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4161\/epi.3.2.6103","volume":"3","author":"RP Sharma","year":"2008","unstructured":"Sharma RP, Tun N, Grayson DR (2008) Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. Epigenetics 3:74\u201380. https:\/\/doi.org\/10.4161\/epi.3.2.6103","journal-title":"Epigenetics"},{"key":"4167_CR159","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuroscience.2017.08.023","volume":"362","author":"S Olmedo-D\u00edaz","year":"2017","unstructured":"Olmedo-D\u00edaz S, Est\u00e9vez-Silva H, Or\u00e4dd G, Af Bjerk\u00e9n S, Marcellino D, Virel A (2017) An altered blood\u2013brain barrier contrib to brain iron accumulation and neuroinflammation in the 6-OHDA rat model Parkinson\u2019s disease. Neuroscience 362:141\u2013151. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.08.023","journal-title":"Neuroscience"},{"issue":"1","key":"4167_CR160","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1186\/s12864-016-3216-y","volume":"17","author":"KM Schachtschneider","year":"2016","unstructured":"Schachtschneider KM, Liu Y, Rund LA, Madsen O, Johnson RW, Groenen MA et al (2016) Impact of neonatal iron deficiency on hippocampal DNA methylation and gene transcription in a porcine biomedical model of cognitive development. BMC Genomics 17(1):856. https:\/\/doi.org\/10.1186\/s12864-016-3216-y","journal-title":"BMC Genomics"},{"issue":"9","key":"4167_CR161","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1074\/jbc.m116.754101","volume":"292","author":"H Gerber","year":"2017","unstructured":"Gerber H, Wu F, Dimitrov M, Garcia Osuna GM, Fraering PC (2017) (2017) Zinc and copper differentially modulate amyloid precursor protein processing by \u03b3-secretase and amyloid-\u03b2 peptide production. J Biol Chem 292(9):3751\u20133767. https:\/\/doi.org\/10.1074\/jbc.m116.754101","journal-title":"J Biol Chem"},{"key":"4167_CR162","doi-asserted-by":"publisher","first-page":"175628642210925","DOI":"10.1177\/17562864221092566","volume":"15","author":"C Wang","year":"2022","unstructured":"Wang C, Zhou C, Guo T, Huang P, Xu X, Zhang M (2022) Association between cigarette smoking and Parkinson\u2019s disease: a neuroimaging study. Ther Adv Neurol Disord 15:17562864221092566. https:\/\/doi.org\/10.1177\/17562864221092566","journal-title":"Ther Adv Neurol Disord"},{"key":"4167_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.60269","volume":"14","author":"X Ren","year":"2020","unstructured":"Ren X, Chen JF (2020) Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms. Front Neurosci 14:602697. https:\/\/doi.org\/10.3389\/fnins.2020.60269","journal-title":"Front Neurosci"},{"issue":"51","key":"4167_CR164","doi-asserted-by":"publisher","first-page":"E12053","DOI":"10.1073\/pnas.181336511","volume":"115","author":"R Yan","year":"2018","unstructured":"Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM (2018) Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson\u2019s disease and DLB. Proc Natl Acad Sci U S A 115(51):E12053\u2013E12062. https:\/\/doi.org\/10.1073\/pnas.181336511","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4167_CR165","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JPD-20252","volume":"11","author":"J Sieurin","year":"2021","unstructured":"Sieurin J, Zhan Y, Pedersen NL, Wirdefeldt K (2021) Neuroticism, smoking, and the risk of Parkinson\u2019s disease. J Parkinsons Dis 11(3):1325\u20131334. https:\/\/doi.org\/10.3233\/JPD-20252","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"4167_CR166","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.2588","volume":"29","author":"P Derkinderen","year":"2014","unstructured":"Derkinderen P, Shannon KM, Brundin P (2014) Gut feelings about smoking and coffee in Parkinson\u2019s disease. Mov Disord 29(8):976\u2013979. https:\/\/doi.org\/10.1002\/mds.2588","journal-title":"Mov Disord"},{"key":"4167_CR167","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2015.0012","volume":"9","author":"M Chin-Chan","year":"2015","unstructured":"Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B (2015) Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9:124. https:\/\/doi.org\/10.3389\/fncel.2015.0012","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"4167_CR168","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","volume":"124","author":"JR Cannon","year":"2011","unstructured":"Cannon JR, Greenamyre JT (2011) The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci 124(2):225\u2013250. https:\/\/doi.org\/10.1093\/toxsci\/kfr239","journal-title":"Toxicol Sci"},{"key":"4167_CR169","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","volume":"131","author":"R Lardenoije","year":"2015","unstructured":"Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HW, Mastroeni D, Coleman P, Lemere CA, Hof PR, van den Hove DL, Rutten BP (2015) The epigenetics of aging and neurodegeneration. Prog Neurobiol 131:21\u201364. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.05.002","journal-title":"Prog Neurobiol"},{"issue":"2","key":"4167_CR170","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/brain\/awac092","volume":"146","author":"H Shams","year":"2023","unstructured":"Shams H, Shao X, Santaniello A, Kirkish G, Harroud A, Ma Q, Isobe N, University of California San Francisco MS-EPIC Team, Schaefer CA, McCauley JL, Cree BAC, Didonna A, Baranzini SE, Patsopoulos NA, Hauser SL, Barcellos LF, Henry RG, Oksenberg JR (2023) Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans. Brain 146(2):645\u2013656. https:\/\/doi.org\/10.1093\/brain\/awac092","journal-title":"Brain"},{"issue":"5","key":"4167_CR171","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","volume":"2","author":"KB Pandey","year":"2009","unstructured":"Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2(5):270\u2013278. https:\/\/doi.org\/10.4161\/oxim.2.5.9498","journal-title":"Oxid Med Cell Longev"},{"key":"4167_CR172","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/914273","volume":"2012","author":"D Vauzour","year":"2012","unstructured":"Vauzour D (2012) Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev 2012:914273. https:\/\/doi.org\/10.1155\/2012\/914273","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"4167_CR173","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1046\/j.1471-4159.2003.02291.x","volume":"88","author":"S Mandel","year":"2004","unstructured":"Mandel S, Weinreb O, Amit T, Youdim MB (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (\u2013)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 88(6):1555\u20131569. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02291.x","journal-title":"J Neurochem"},{"key":"4167_CR174","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.bbagen.2016.06.022","volume":"10","author":"J Das","year":"2016","unstructured":"Das J, Ramani R, Suraju MO (2016) Polyphenol compounds and PKC signaling. Biochim Biophys Acta 10:2107\u20132121. https:\/\/doi.org\/10.1016\/j.bbagen.2016.06.022","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4167_CR175","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/J.neurobiolaging.2014.08.029","volume":"36","author":"I Luccarini","year":"2015","unstructured":"Luccarini I, Grossi C, Rigacci S, Coppi E, Pugliese AM, Pantano D, La-Marca G, Ed-Dami T, Berti A, Stefani M, Casamenti F (2015) Oleuropein aglycone protects against pyroglutamylated-3 amyloid-\u00df toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging 36(2):648\u2013663. https:\/\/doi.org\/10.1016\/J.neurobiolaging.2014.08.029","journal-title":"Neurobiol Aging"},{"issue":"1","key":"4167_CR176","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mnfr.201300195","volume":"58","author":"VB Ayissi","year":"2014","unstructured":"Ayissi VB, Ebrahimi A, Schluesenner H (2014) Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res 58(1):22\u201332. https:\/\/doi.org\/10.1002\/mnfr.201300195","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"4167_CR177","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bcp.2012.09.027","volume":"85","author":"N Khan","year":"2013","unstructured":"Khan N, Mukhtar H (2013) Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem Pharmacol 85(5):667\u2013672. https:\/\/doi.org\/10.1016\/j.bcp.2012.09.027","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4167_CR178","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/biof.1063","volume":"39","author":"A Monroy","year":"2013","unstructured":"Monroy A, Lithgow GJ, Alavez S (2013) Curcumin and neurodegenerative diseases. BioFactors 39(1):122\u2013132. https:\/\/doi.org\/10.1002\/biof.1063","journal-title":"BioFactors"},{"issue":"2018","key":"4167_CR179","doi-asserted-by":"publisher","first-page":"8134902","DOI":"10.1155\/2018\/8134902","volume":"15","author":"L Zhang","year":"2018","unstructured":"Zhang L, Fang Y, Cheng X, Lian Y, Zeng Z, Wu C, Zhu H, Xu H (2018) The potential protective effect of curcumin on amyloid-\u03b2-42 induced cytotoxicity in HT-22 cells. Biomed Res Int 15(2018):8134902. https:\/\/doi.org\/10.1155\/2018\/8134902","journal-title":"Biomed Res Int"},{"issue":"4","key":"4167_CR180","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1293\/tox.2015-0020","volume":"28","author":"XJ He","year":"2015","unstructured":"He XJ, Uchida K, Megumi C, Tsuge N, Nakayama H (2015) Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in C57BL mice. J Toxicol Pathol 28(4):197\u2013206. https:\/\/doi.org\/10.1293\/tox.2015-0020","journal-title":"J Toxicol Pathol"},{"issue":"3","key":"4167_CR181","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14(3):457\u2013487. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4167_CR182","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt MF, Gan ZY, Komander D, Dewson G (2021) Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ 28(2):570\u2013590. https:\/\/doi.org\/10.1038\/s41418-020-00706-7","journal-title":"Cell Death Differ"},{"issue":"1","key":"4167_CR183","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/cam.3.1.7483","volume":"3","author":"J Wang","year":"2009","unstructured":"Wang J, He Z (2009) NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adh Migr 3(1):77\u201387. https:\/\/doi.org\/10.4161\/cam.3.1.7483","journal-title":"Cell Adh Migr"},{"issue":"4","key":"4167_CR184","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tips.2020.01.006","volume":"41","author":"R Krauss","year":"2020","unstructured":"Krauss R, Bosanac T, Devraj R, Engber T, Hughes RO (2020) Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration. Trends Pharmacol Sci 41(4):281\u2013293. https:\/\/doi.org\/10.1016\/j.tips.2020.01.006","journal-title":"Trends Pharmacol Sci"},{"key":"4167_CR185","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2013.12.016","volume":"253","author":"MA Tegenge","year":"2014","unstructured":"Tegenge MA, Rajbhandari L, Shrestha S, Mithal A, Hosmane S, Venkatesan A (2014) Curcumin protects axons from degeneration in the setting of local neuroinflammation. Exp Neurol 253:102\u2013110. https:\/\/doi.org\/10.1016\/j.expneurol.2013.12.016","journal-title":"Exp Neurol"},{"key":"4167_CR186","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fnins.2019.01223","volume":"13","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zhuang Z, Lu Y et al (2019) Curcumin mitigates neuro-inflammation by modulating microglia polarization through inhibiting TLR4 axis signaling pathway following experimental subarachnoid hemorrhage. Front Neurosci 13:1223. https:\/\/doi.org\/10.3389\/fnins.2019.01223","journal-title":"Front Neurosci"},{"key":"4167_CR187","volume-title":"Curcumin for neurological and psychiatric disorders","author":"RB Mythri","year":"2019","unstructured":"Mythri RB, Srinivas Bharath MM (2019) Curcumin for neurological and psychiatric disorders. Academic Press"},{"issue":"5","key":"4167_CR188","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10616-019-00338-x","volume":"71","author":"T Vasanthkumar","year":"2019","unstructured":"Vasanthkumar T, Hanumanthappa M, Lakshminarayana R (2019) Curcumin and capsaicin modulates LPS induced expression of COX-2, IL-6 and TGF-\u03b2 in human peripheral blood mononuclear cells. Cytotechnology 71(5):963\u2013976. https:\/\/doi.org\/10.1007\/s10616-019-00338-x","journal-title":"Cytotechnology"},{"issue":"4","key":"4167_CR189","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1208\/s12248-014-9605-8","volume":"16","author":"Y Deng","year":"2014","unstructured":"Deng Y, Lu X, Wang L et al (2014) Curcumin inhibits the AKT\/NF-\u03baB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line. AAPS J 16(4):649\u2013657. https:\/\/doi.org\/10.1208\/s12248-014-9605-8","journal-title":"AAPS J"},{"issue":"2","key":"4167_CR190","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/scd.2006.15.165","volume":"15","author":"SK Kang","year":"2006","unstructured":"Kang SK, Cha SH, Jeon HG (2006) Curcumin-induced histone hypoacetylation enhances caspase-3-dependent glioma cell death and neurogenesis of neural progenitor cells. Stem Cells Dev 15(2):165\u2013174. https:\/\/doi.org\/10.1089\/scd.2006.15.165","journal-title":"Stem Cells Dev"},{"issue":"3","key":"4167_CR191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091303","volume":"9","author":"X Zhu","year":"2014","unstructured":"Zhu X, Li Q, Chang R et al (2014) Curcumin alleviates neuropathic pain by inhibiting p300\/CBP histone acetyltransferase activity-regulated expression of BDNF and cox-2 in a rat model. PLoS ONE 9(3):e91303. https:\/\/doi.org\/10.1371\/journal.pone.0091303","journal-title":"PLoS ONE"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04167-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04167-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04167-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T06:04:52Z","timestamp":1723097092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04167-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":191,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4167"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04167-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"type":"print","value":"0364-3190"},{"type":"electronic","value":"1573-6903"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no competing interest in any capacity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}